Cancer
- Cancer PHGKB -
What's New
Last Posted: Nov 24, 2019
- Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib
JAMA Network Open, November 22, 2019 - Machine Learning Algorithm for Genome-Derived Prediction of Tumor Type
ASCO Post, November 2019 - Biomarker-Driven Oncology Clinical Trials: Key Design Elements, Types, Features, and Practical Considerations
C Hu et al, JCO Precision Oncology, October 2019 - Communication and Decision Making for Individuals with Inherited Cancer Syndromes
NCI, November 2019 - Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass.
Oliveira Douglas Nogueira Perez et al. PloS one 2019 (11) e0225249 - Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
Hellmann Matthew D et al. The New England journal of medicine 2019 Nov (21) 2020-2031 - Study Suggests Repurposed Drugs Might Treat Aggressive Lung Cancer
NIH Director's Blog, November 19, 2019 - The mutational footprints of cancer therapies
O Pich et al, Nature Genetics, November 18, 2019 - Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer
H Sarvas et al, JNCI, November 2019 - Can skin cancer diagnosis be transformed by AI?
A Esteva et al, Lancet Digital Health, November 2019 - Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care
A Penson et al,JAMA Oncology, November 14, 2019 - Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer
T Mukama, et al. JAMA Oncology, November 14, 2019 - Toward Risk-Stratified Breast Cancer Screening: Considerations for Changes in Screening Guidelines
GL Gierach et al, JAMA Oncology, November 14, 2019 - Tumor Origins Through Genomic Profiles
ET Liu et al, JAMA Oncology, November 14, 2019 - Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures
I Sobhani, et al, PNAS, November 11, 2019
.png)
No hay comentarios:
Publicar un comentario